Immix Biopharma, Inc. IMMX Income taxes receivable
Income taxes receivable at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReceivable.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s income taxes receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s income taxes receivable?
- Immix Biopharma, Inc. (IMMX) reported income taxes receivable of $0 in Q1 2026.
- What is the long-term trend for Immix Biopharma, Inc.'s income taxes receivable?
- Over 5 years (2020 to 2025), Immix Biopharma, Inc.'s income taxes receivable has grown at a -100.0% compound annual growth rate (CAGR), from $127.44K to $0.